Literature DB >> 27220324

Atypical speech and language development: a consensus study on clinical signs in the Netherlands.

Margot I Visser-Bochane1, Ellen Gerrits2,3, Cees P van der Schans1,4, Sijmen A Reijneveld5, Margreet R Luinge1,6.   

Abstract

BACKGROUND: Atypical speech and language development is one of the most common developmental difficulties in young children. However, which clinical signs characterize atypical speech-language development at what age is not clear. AIM: To achieve a national and valid consensus on clinical signs and red flags (i.e. most urgent clinical signs) for atypical speech-language development in children from 1 to 6 years of age. METHODS & PROCEDURES: A two-round Delphi study in the Netherlands with a national expert panel (n = 24) of speech and language therapists was conducted. The panel members responded to web-based questionnaires addressing clinical signs. Consensus was defined as ≥ 70% of the experts agreeing on an issue. OUTCOMES &
RESULTS: The first round resulted in a list of 161 characteristics of atypical speech and language development. The second round led to agreement on 124 clinical signs and 34 red flags. CONCLUSIONS & IMPLICATIONS: Dutch national consensus concerns 17-23 clinical signs per age year for the description of an atypical speech-language development in young children and three to 10 characteristics per age year being red flags for atypical speech-language development. This consensus contributes to early identification and diagnosis of children with atypical speech-language development, awareness and research.
© 2016 Royal College of Speech and Language Therapists.

Entities:  

Mesh:

Year:  2016        PMID: 27220324     DOI: 10.1111/1460-6984.12251

Source DB:  PubMed          Journal:  Int J Lang Commun Disord        ISSN: 1368-2822            Impact factor:   3.020


  1 in total

1.  Clinical Characteristics and Genetic Etiology of Children With Developmental Language Disorder.

Authors:  Marielle B Plug; Vivian van Wijngaarden; Hester de Wilde; Ellen van Binsbergen; Inge Stegeman; Marie-José H van den Boogaard; Adriana L Smit
Journal:  Front Pediatr       Date:  2021-07-01       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.